Buy Crypto Markets Spot FuturesBTC Earn Event Centre Rewards Hub

Standard BioTools Inc. (LAB)

NASDAQ

$0,69

$-0,01

(-1,15%)

Pre-Market

Standard BioTools Inc. (LAB) Live Price Chart

Last updated: ⁦2026-09-16 10:31:00⁩. Prices reflect the latest pre-market trading data. Stock price data is sourced from Massive.

Summary

Standard BioTools Inc. (LAB) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $0,69, with a market capitalisation of $273,43M and a P/E ratio of 3,19. Over the past 52 weeks, its price has ranged from $0,63 to $1,72. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

Market Cap	$273,43M
Open	$0,68
Day's High	$18,68
Day's Low	$0,63
Previous Close	$0,70
Volume	795,60K
Average Volume	2,75M
P/E Ratio	3,19
52-Week High	$1,72
52-Week Low	$0,63
Dividend Yield	--
Earnings Date	--

Standard BioTools Inc. (LAB) Pre-Market Stock Price

Standard BioTools Inc. (LAB) is trading at $0,70 in pre-market trading as of 2026-09-15 23:31:00, up 0,50% ($0,00) from the previous close of $0,70

Pre-market trading shows how investors are pricing LAB before the regular session opens. The current pre-market price is above the previous close, indicating positive early trading sentiment.

Standard BioTools Inc. (LAB) 7-Day Stock Price Change

Over the past seven days, Standard BioTools Inc. (LAB) moved from $0,69 to $0,69, representing a gain of 0,07% ($0,00).

The stock traded between $0,66 and $0,73 during the period. The latest price is near the lower end of the 7-day range, indicating range-bound.

The average daily volume was 1,58 million shares, down versus the previous seven-day period, indicating lower trading activity.

LAB 52-Week Price Position

Position in Range: 5,6%

52W Low$0,63

52W High$1,72

LAB is currently trading at $0,69, placing it 5,6% of the way from its 52-week low of $0,63 to its 52-week high of $1,72. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.

What is Standard BioTools Inc. (LAB)?

Standard BioTools Inc develops, manufactures, and sells technologies that help biomedical researchers in their search for developing medicines faster. Its tools provide insights into health and disease using proprietary mass cytometry and microfluidics technologies, which serve applications in proteomics and genomics, respectively. The company operates in one segment. Its technology includes: Genomics; Single-cell proteomics; Spatial proteomics. Its platforms include: Biomark X9 System, CyTOF XT system, and Hyperion XTi Imaging System. The company offers a diverse range of instrumentation, consumables, and services that generate high-quality data across early discovery, translational and clinical research. Geographically, it operates in Americas; EMEA and Asia-Pacific.

Standard BioTools Inc. Information

Industry	PHARMACEUTICAL PREPARATIONS
Employees	389
Exchange	NASDAQ
Company Website	https://www.standardbio.com

How to Buy Standard BioTools Inc. (LAB) Stock on MEXC

Eligible investors can buy real shares of Standard BioTools Inc. (LAB) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account

Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licenced broker.

Step 2: Transfer USDT to Your RealStocks Account

Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.

Step 3: Search for LAB and Place Your Order

Open the RealStocks trading page and search for LAB. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is Standard BioTools Inc. (LAB) stock price today?

Standard BioTools Inc. (LAB) is currently trading at $ 0,69, down 1,51% ($0,01) from the previous close of $ 0,70. Intraday prices update in real time during regular trading hours.

2.Is LAB stock going up or down today?

As of 2026-09-15 23:31:00, LAB is trading at $ 0,69, down 1,51% ($0,01) from its previous close of $ 0,70. The stock has traded between $ 0,63 and $ 18,68 during today’s regular session. Past price movements do not guarantee future results.

3.What is LAB pre-market price?

As of 2026-09-15 23:31:00, LAB is trading at $ 0,70 in pre-market trading, up 0,50% ($0,00) from the previous close of $ 0,70. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.

4.What is LAB after-hours price?

As of 2026-09-15 23:31:00, LAB is trading at $ 0,69 in after-hours trading, down 1,08% ($0,01) from the regular-session close of $ 0,70. After-hours prices may differ from the regular session’s opening price due to lower liquidity and wider bid-ask spreads.

5.Is LAB stock trading now?

LAB trades on the NASDAQ exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.

6.Where does LAB sit relative to its 52-week high and low?

Over the past 52 weeks, LAB has traded between a low of $ 0,63 and a high of $ 1,72. At $ 0,69, the stock is positioned 5,6% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.

7.What sector is Standard BioTools Inc. in?

Standard BioTools Inc. (LAB) operates in the PHARMACEUTICAL PREPARATIONS sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.

8.What is Standard BioTools Inc.'s market capitalisation and where is it listed?

Standard BioTools Inc. is listed on the NASDAQ exchange with a market capitalisation of $ 273,43M. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.

9.How is LAB valued in terms of P/E ratio and EPS?

LAB trades at a P/E ratio of 3,19, based on trailing-twelve-month EPS of $ 0,22. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.

10.Does Standard BioTools Inc. pay a dividend?

Standard BioTools Inc. pays an indicated annual cash dividend of $ 0,00 per share, with a current dividend yield of 0,00% based on the latest share price. Dividend policies are subject to change at the board's discretion.